*Held on Monday, February 11, 2019 and will be in CHS 13-105 Reinhard Luhrmann, Ph.D. Director, Max Planck Institute for Biophysical Chemistry Max Planck Institute for Biophysical Chemistry
Arnold Berk, M.D. Professor, Microbiology, Immunology & Molecular Genetics
Jeffrey Long, Ph.D. Director, Cell & Developmental Biology Home Area Professor, Molecular, Cell & Developmental Biology
Aseem Ansari, Ph.D. “Designing Synthetic Transcription Factors” Professor of Chemical Genomics and Synthetic Biology Department of Biochemistry and Genome Center University of Wisconsin-Madison
Atsushi Nakano, M.D., Ph.D. Associate Professor, Molecular, Cell & Developmental Biology
"Development and function of innate-like alpha beta T cells" Mitchell Kronenberg, Ph.D. President & Chief Scientific Officer, Division of Developmental Immunology La Jolla Institute for Immunology
Jason Ernst, Ph.D. Associate Professor, Biological Chemistry & Computer Science
Robert Clubb, Ph.D. Professor, Chemistry & Biochemistry, Biochemistry, Molecular Biology
Arjun Raj, Ph.D. "Free will, determinism, and therapy resistance in cancer" Associate Professor, Bioengineering University of Pennsylvania
Matthew Tyska, Ph.D. Cornelius Vanderbilt Chair in Cell & Developmental Biology Vanderbilt Institute for Infection, Immunology and Inflammation Vanderbilt University Medical Center
Robert Schiestl, Ph.D. “Novel probiotics persisting more than 60 days in the human guts and reducing inflammation in the entire body” Professor, Pathology and Environmental Health Sciences
Robert Spitale, Ph.D. Assistant Professor, Pharmaceutical Sciences University of California, Irvine
